B. Ziaeian and G. C. Fonarow, Epidemiology and aetiology of heart failure, Nat. Rev. Cardiol, vol.13, pp.368-378, 2016.

V. L. Roger, Trends in heart failure incidence and survival in a community-based population, JAMA, vol.292, p.344, 2004.

P. Ponikowski, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur. Heart J, vol.37, pp.2129-2200, 2016.

S. Kenchaiah, Obesity and the risk of heart failure, N. Engl. J. Med, vol.347, pp.305-313, 2002.

T. J. Cahill, H. Ashrafian, and H. Watkins, Genetic cardiomyopathies causing heart failure, Circ. Res, vol.113, pp.660-675, 2013.

M. P. Lindgren, A Swedish Nationwide Adoption Study of the heritability of heart failure, JAMA Cardiol, vol.3, pp.703-710, 2018.

K. G. Aragam, Phenotypic refinement of heart failure in a National Biobank facilitates genetic discovery, Circulation, vol.139, pp.489-501, 2019.

N. L. Smith, Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium, Circ. Cardiovasc. Genet, vol.3, pp.256-266, 2010.

B. Meder, A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy, Eur. Heart J, vol.35, pp.1069-1077, 2014.

U. Esslinger, Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy, PLoS One, vol.12, p.172995, 2017.

E. Villard, A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy, Eur. Heart J, vol.32, pp.1065-1076, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00616568

D. Smith, G. Ebrahim, and S. , Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?, Int. J. Epidemiol, vol.32, pp.1-22, 2003.

B. K. Bulik-sullivan, LD Score regression distinguishes confounding from polygenicity in genome-wide association studies, Nat. Genet, vol.47, pp.291-295, 2015.

E. J. Benjamin, American Heart Association. Circulation, vol.137, pp.67-492, 2018.

D. Welter, The NHGRI GWAS catalog, a curated resource of SNP-trait associations, Nucleic Acids Res, vol.42, pp.1001-1006, 2014.

P. S. Wild, Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function, J. Clin. Invest, vol.127, pp.1798-1812, 2017.

C. Roselli, Multi-ethnic genome-wide association study for atrial fibrillation, Nat. Genet, vol.50, pp.1225-1233, 2018.

M. Nikpay, A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease, Nat. Genet, vol.47, pp.1121-1130, 2015.

H. R. Warren, Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk, Nat. Genet, vol.49, pp.403-415, 2017.

A. E. Locke, Genetic studies of body mass index yield new insights for obesity biology, Nature, vol.518, pp.197-206, 2015.

R. N. Eppinga, Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality, Nat. Genet, vol.48, pp.1557-1563, 2016.

C. J. Willer, Discovery and refinement of loci associated with lipid levels, Nat. Genet, vol.45, pp.1274-1283, 2013.

R. A. Scott, An expanded genome-wide association study of type 2 diabetes in Europeans, Diabetes, vol.66, pp.2888-2902, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01832132

R. Santhanakrishnan, Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction, Circulation, vol.133, pp.484-492, 2016.

Z. Zhu, Causal associations between risk factors and common diseases inferred from GWAS summary data, Nat. Commun, vol.9, pp.1-12, 2018.

C. A. De-leeuw, J. M. Mooij, T. Heskes, and D. Posthuma, MAGMA: generalized gene-set analysis of GWAS data, PLoS Comput. Biol, vol.11, p.1004219, 2015.

F. Domínguez, Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations, J. Am. Coll. Cardiol, vol.72, pp.2471-2481, 2018.

L. Zeng, Cis-epistasis at the LPA locus and risk of coronary artery disease, 2019.

U. Võsa, Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis, 2018.

C. Giambartolomei, Bayesian test for colocalisation between pairs of genetic association studies using summary statistics, PLoS Genet, vol.10, p.1004383, 2014.

B. B. Sun, Genomic atlas of the human plasma proteome, Nature, vol.558, pp.73-79, 2018.

N. Frey, Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation, J. Clin. Invest, vol.118, pp.3598-3608, 2008.

J. D. Molkentin, Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells, Circ. Res, vol.113, pp.16-19, 2013.

A. Beqqali, CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function, J. Cell. Sci, vol.123, pp.1141-1150, 2010.

C. Behl, Breaking BAG: the co-chaperone BAG3 in health and disease, Trends Pharmacol. Sci, vol.37, pp.672-688, 2016.

S. Tane, CDK inhibitors, p21Cip1 and p27Kip1, participate in cell cycle exit of mammalian cardiomyocytes, Biochem. Biophys. Res. Commun, vol.443, pp.1105-1109, 2014.

E. Mattioli, Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS, Aging Cell, vol.17, p.12824, 2018.

L. M. Boyden, Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities, Nature, vol.482, pp.98-102, 2012.

S. Sciarretta, F. Palano, G. Tocci, R. Baldini, and M. Volpe, Antihypertensive treatment and development of heart failure in hypertension, Arch. Intern. Med, vol.171, pp.384-394, 2011.

R. S. Velagaleti and R. S. Vasan, Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?, Cardiol. Clin, vol.25, pp.487-495, 2007.

V. L. Roger, Epidemiology of heart failure, Circ. Res, vol.113, pp.646-659, 2013.

I. Ntalla, Genetic risk score for coronary disease identifies predispositions to cardiovascular and noncardiovascular diseases, J. Am. Coll. Cardiol, vol.73, pp.2932-2942, 2019.

A. Fry, Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population, Am. J. Epidemiol, vol.186, pp.1026-1034, 2017.

L. He, Causal effects of cardiovascular risk factors on onset of major agerelated diseases: a time-to-event Mendelian randomization study, Exp. Gerontol, vol.107, pp.74-86, 2018.

T. Fall, The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis, PLoS Med, vol.10, p.1001474, 2013.

R. Dhingra, J. M. Gaziano, and L. Djoussé, Chronic kidney disease and the risk of heart failure in men, Circ. Heart Fail, vol.4, pp.138-144, 2011.

D. Nanchen, Resting heart rate and the risk of heart failure in healthy adults, Circ. Heart Fail, vol.6, pp.403-410, 2013.

, The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing, Nature, vol.467, pp.1061-1073, 2010.

I. Hapmap and . Consortium, A second generation human haplotype map of over 3.1 million SNPs, Nature, vol.449, pp.851-861, 2007.

. Haplotype-reference-consortium, A reference panel of 64,976 haplotypes for genotype imputation, Nat. Genet, vol.48, pp.1279-1283, 2016.

M. Mitt, Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel, Eur. J. Hum. Genet, vol.25, pp.869-876, 2017.

P. Loh, P. F. Palamara, and A. L. Price, Fast and accurate long-range phasing in a UK Biobank cohort, Nat. Genet, vol.48, pp.811-816, 2016.

Y. Li, C. J. Willer, J. Ding, P. Scheet, and G. R. Abecasis, MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes, Genet. Epidemiol, vol.34, pp.816-834, 2010.

O. Delaneau, J. Zagury, and J. Marchini, Improved whole-chromosome phasing for disease and population genetic studies, Nat. Methods, vol.10, pp.5-6, 2013.

C. Fuchsberger, G. R. Abecasis, and D. Hinds, A. minimac2: faster genotype imputation, Bioinformatics, vol.31, pp.782-784, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01609428

B. N. Howie, P. Donnelly, and J. Marchini, A flexible and accurate genotype imputation method for the next generation of genome-wide association studies, PLoS Genet, vol.5, p.1000529, 2009.

A. Kong, Detection of sharing by descent, long-range phasing and haplotype imputation, Nat. Genet, vol.40, pp.1068-1075, 2008.

Y. S. Aulchenko, M. V. Struchalin, and C. M. Van-duijn, ProbABEL package for genome-wide association analysis of imputed data, BMC Bioinforma, vol.11, p.134, 2010.

Z. Kutalik, Methods for testing association between uncertain genotypes and quantitative traits, Biostatistics, vol.12, pp.1-17, 2011.

C. C. Chang, Second-generation PLINK: rising to the challenge of larger and richer datasets, Gigascience, vol.4, p.7, 2015.

J. Marchini, B. Howie, S. Myers, G. Mcvean, and P. Donnelly, A new multipoint method for genome-wide association studies by imputation of genotypes, Nat. Genet, vol.39, pp.906-913, 2007.

, R Core team. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2015.

T. W. Winkler, Quality control and conduct of genome-wide association meta-analyses, Nat. Protoc, vol.9, pp.1192-1212, 2014.

, The 1000 Genomes Project Consortium. A global reference for human genetic variation, Nature, vol.526, pp.68-74, 2015.

J. A. Sinnott and P. Kraft, Artifact due to differential error when cases and controls are imputed from different platforms, Hum. Genet, vol.131, pp.111-119, 2012.

E. O. Johnson, Imputation across genotyping arrays for genome-wide association studies: assessment of bias and a correction strategy, Hum. Genet, vol.132, pp.509-522, 2013.

B. Devlin and K. Roeder, Genomic control for association studies, Biometrics, vol.55, pp.997-1004, 1999.

C. J. Willer, Y. Li, and G. R. Abecasis, METAL: fast and efficient meta-analysis of genomewide association scans, Bioinformatics, vol.26, pp.2190-2191, 2010.

K. Watanabe, E. Taskesen, . Bochoven, and D. Posthuma, Functional mapping and annotation of genetic associations with FUMA, Nat. Commun, vol.8, pp.1-11, 2017.

C. Bycroft, The UK Biobank resource with deep phenotyping and genomic data, Nature, vol.562, pp.203-209, 2018.

J. P. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, Measuring inconsistency in meta-analyses, BMJ, vol.327, pp.557-560, 2003.

M. Ashburner, Gene Ontology: tool for the unification of biology, Nat. Genet, vol.25, pp.25-29, 2000.

M. Kircher, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet, vol.46, pp.310-315, 2014.

G. Consortium, The Genotype-Tissue Expression (GTEx) project, Nat. Genet, vol.45, pp.580-585, 2013.

O. Delaneau, A complete tool set for molecular QTL discovery and analysis, Nat. Commun, vol.8, p.15452, 2017.

J. T. Leek, 0svaseq: removing batch effects and other unwanted noise from sequencing data, Nucleic Acids Res, vol.42, 2014.

G. Consortium, Genetic effects on gene expression across human tissues, Nature, vol.550, pp.204-213, 2017.

A. N. Barbeira, Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics, Nat. Commun, vol.9, p.1825, 2018.

J. Macarthur, The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog), Nucleic Acids Res, vol.45, pp.896-901, 2017.

M. Gorski, Genomes-based meta-analysis identifies 10 novel loci for kidney function, Sci. Rep, vol.7, p.45040, 1000.

J. Yang, S. H. Lee, M. E. Goddard, and P. M. Visscher, GCTA: a tool for genome-wide complex trait analysis, Am. J. Hum. Genet, vol.88, pp.76-82, 2011.

G. Hemani, The MR-Base platform supports systematic causal inference across the human phenome, vol.7, p.34408, 2018.

S. Burgess, A. Butterworth, and S. G. Thompson, Mendelian randomization analysis with multiple genetic variants using summarized data, Genet. Epidemiol, vol.37, pp.658-665, 2013.

J. Bowden, G. Davey-smith, and S. Burgess, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression, Int. J. Epidemiol, vol.44, pp.512-525, 2015.

O. O. Yavorska and S. Burgess, MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data, Int. J. Epidemiol, vol.46, pp.1734-1739, 2017.

, Thomas Morgan 31,68 , Andrew D. Morris 69 , Andrew P. Morris 32,63 , Alanna C. Morrison 26 , Michael W. Nagle 12 , Christopher P. Nelson 59 , Alexander Niessner 70, Guðmundur Thorgeirsson 9, vol.12, p.105

, 5 Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard

P. A. Philadelphia and U. , 20 Department of Neurobiology, Care Sciences and Society/ Section of Family Medicine and Primary Care, Cardiovascular Research Center, Massachusetts General Hospital, vol.9, issue.23, p.26

D. Geisinger, P. A. , and U. , 28 Division of Preventive Medicine, Brigham and Women's Hospital, 31 Novartis Institutes for Biomedical Research, vol.29

, 38 DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany. 39 Cardiovascular Division, Ninewells Hospital and Medical School, p.40

, Regeneron Pharmaceuticals

, 86 Institute for Translational Genomics and Population Sciences, LABiomed and Departments of Pediatrics at Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, vol.75, p.91

C. Glaxosmithkline, P. A. , and U. , Servier Cardiovascular Center for Therapeutic Innovation, 50 rue Carnot, 92284 Suresnes, Massachusetts General Hospital

, 106 Division of Psychiatry

, Claudia Schurmann, vol.22